Patents by Inventor Ralph C. Budd

Ralph C. Budd has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • GAMMA-DELTA T CELL LIGANDS FOR CANCER IMMUNOTHERAPY
    Publication number: 20220252594
    Abstract: Provided herein are compositions and methods relating to ?? T cells. Specifically, methods of screening samples for human ?? T cells surface ligands using a soluble human ?? T cell receptor tetramer are provided. Such ligands may be useful in the treatment of diseases, for example, cancer.
    Type: Application
    Filed: May 27, 2020
    Publication date: August 11, 2022
    Applicant: The University of Vermont and State Agricultural College
    Inventors: Ralph C. Budd, Cheryl Collins
  • Augmenting the immune response by promoting cell death of immune cells
    Patent number: 10842843
    Abstract: Methods and products for producing an antigen specific immune response are provided. The methods involve administration of a caspase inhibitor to a subject.
    Type: Grant
    Filed: September 17, 2019
    Date of Patent: November 24, 2020
    Assignee: The University of Vermont and State Agricultural College
    Inventors: Ralph C. Budd, Cheryl Collins
  • AUGMENTING THE IMMUNE RESPONSE BY PROMOTING CELL DEATH OF IMMUNE CELLS
    Publication number: 20200000869
    Abstract: Methods and products for producing an antigen specific immune response are provided. The methods involve administration of a caspase inhibitor to a subject.
    Type: Application
    Filed: September 17, 2019
    Publication date: January 2, 2020
    Applicant: The University of Vermont and State Agricultural College
    Inventors: Ralph C. Budd, Cheryl Collins
  • Augmenting the immune response by promoting cell death of immune cells
    Patent number: 10456441
    Abstract: Methods and products for producing an antigen specific immune response are provided. The methods involve administration of a caspase inhibitor to a subject.
    Type: Grant
    Filed: February 8, 2018
    Date of Patent: October 29, 2019
    Assignee: The University of Vermont and State Agricultural College
    Inventors: Ralph C. Budd, Cheryl Collins
  • AUGMENTING THE IMMUNE RESPONSE BY PROMOTING CELL DEATH OF IMMUNE CELLS
    Publication number: 20180169178
    Abstract: Methods and products for producing an antigen specific immune response are provided. The methods involve administration of a caspase inhibitor to a subject.
    Type: Application
    Filed: February 8, 2018
    Publication date: June 21, 2018
    Applicant: The University of Vermont and State Agricultural College
    Inventor: Ralph C. Budd
  • Augmenting the immune response by promoting cell death of immune cells
    Patent number: 9925230
    Abstract: Methods and products for producing an antigen specific immune response are provided. The methods involve administration of a caspase inhibitor to a subject.
    Type: Grant
    Filed: July 22, 2015
    Date of Patent: March 27, 2018
    Assignee: The University of Vermont and State Agricultural College
    Inventor: Ralph C. Budd
  • AUGMENTING THE IMMUNE RESPONSE BY PROMOTING CELL DEATH OF IMMUNE CELLS
    Publication number: 20160030538
    Abstract: Methods and products for producing an antigen specific immune response are provided. The methods involve administration of a caspase inhibitor to a subject.
    Type: Application
    Filed: July 22, 2015
    Publication date: February 4, 2016
    Applicant: The University of Vermont and State Agricultural College
    Inventor: Ralph C. Budd
  • Caspase inhibitors for inhibiting blood cell proliferation and for treating autoimmune diseases
    Publication number: 20040209813
    Abstract: The use of inhibitors of cysteine aspartate proteins (caspases) for treating diseases or disorders caused by a hyperproliferation of peripheral blood lymphocytes is disclosed. The use of caspase inhibitors for suppressing the immune system is also disclosed.
    Type: Application
    Filed: April 21, 2004
    Publication date: October 21, 2004
    Inventors: Ralph C. Budd, Jurg Tschopp, Takao Kataoka
  • Caspase inhibitors for inhibiting blood cell proliferation and for treating autoimmune diseases
    Publication number: 20020086832
    Abstract: The use of inhibitors of cysteine aspartate proteins (caspases) for treating diseases or disorders caused by a hyperproliferation of peripheral blood lymphocytes is disclosed. The use of caspase inhibitors for suppressing the immune system is also disclosed.
    Type: Application
    Filed: October 9, 2001
    Publication date: July 4, 2002
    Applicant: APOTECH RESEARCH AND DEVELOPMENT LTD.
    Inventors: Ralph C. Budd, Jurg Tschopp, Takao Kataoka